ethylisopropylamiloride has been researched along with Bile Duct Diseases in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Bile Duct Diseases: Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, H | 1 |
| LeSage, G | 1 |
| DeMorrow, S | 1 |
| Alvaro, D | 1 |
| Ueno, Y | 1 |
| Venter, J | 1 |
| Glaser, S | 1 |
| Mancino, MG | 1 |
| Marucci, L | 1 |
| Benedetti, A | 1 |
| Alpini, G | 1 |
1 other study available for ethylisopropylamiloride and Bile Duct Diseases
| Article | Year |
|---|---|
The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Amiloride; Animals; Anti-Arrhythmia | 2007 |